Literature DB >> 23534832

Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

Aman Khurana1, Hossein Nejadnik, Fanny Chapelin, Olga Lenkov, Rakhee Gawande, Sungmin Lee, Sandeep N Gupta, Nooshin Aflakian, Nikita Derugin, Solomon Messing, Guiting Lin, Tom F Lue, Laura Pisani, Heike E Daldrup-Link.   

Abstract

AIM: To develop a clinically applicable MRI technique for tracking stem cells in matrix-associated stem-cell implants, using the US FDA-approved iron supplement ferumoxytol. MATERIALS &
METHODS: Ferumoxytol-labeling of adipose-derived stem cells (ADSCs) was optimized in vitro. A total of 11 rats with osteochondral defects of both femurs were implanted with ferumoxytol- or ferumoxides-labeled or unlabeled ADSCs, and underwent MRI up to 4 weeks post matrix-associated stem-cell implant. The signal-to-noise ratio of different matrix-associated stem-cell implant was compared with t-tests and correlated with histopathology.
RESULTS: An incubation concentration of 500 µg iron/ml ferumoxytol and 10 µg/ml protamine sulfate led to significant cellular iron uptake, T2 signal effects and unimpaired ADSC viability. In vivo, ferumoxytol- and ferumoxides-labeled ADSCs demonstrated significantly lower signal-to-noise ratio values compared with unlabeled controls (p < 0.01). Histopathology confirmed engraftment of labeled ADSCs, with slow dilution of the iron label over time.
CONCLUSION: Ferumoxytol can be used for in vivo tracking of stem cells with MRI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23534832      PMCID: PMC3816126          DOI: 10.2217/nnm.12.198

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  64 in total

1.  Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells.

Authors:  Stacey Cromer Berman; Chulani Galpoththawela; Assaf A Gilad; Jeff W M Bulte; Piotr Walczak
Journal:  Magn Reson Med       Date:  2010-10-06       Impact factor: 4.668

2.  Cartilage damage as a result of hemarthrosis in a human in vitro model.

Authors:  G Roosendaal; M E Vianen; H M van den Berg; F P Lafeber; J W Bijlsma
Journal:  J Rheumatol       Date:  1997-07       Impact factor: 4.666

3.  Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?

Authors:  Gun-Il Im; Yong-Woon Shin; Kee-Byung Lee
Journal:  Osteoarthritis Cartilage       Date:  2005-10       Impact factor: 6.576

4.  Cell motility of neural stem cells is reduced after SPIO-labeling, which is mitigated after exocytosis.

Authors:  Stacey M Cromer Berman; C Joanne Wang; Inema Orukari; Andre Levchenko; Jeff W M Bulte; Piotr Walczak
Journal:  Magn Reson Med       Date:  2012-02-28       Impact factor: 4.668

5.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

6.  Trauma-associated inflammatory response impairs embryonic stem cell survival and integration after implantation into injured rat brain.

Authors:  Marek Molcanyi; Peter Riess; Kristine Bentz; Marc Maegele; Jürgen Hescheler; Bernhard Schäfke; Thorsten Trapp; Edmund Neugebauer; Norfrid Klug; Ute Schäfer
Journal:  J Neurotrauma       Date:  2007-04       Impact factor: 5.269

7.  MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis.

Authors:  Alexander Nedopil; Christopher Klenk; Cy Kim; Siyuan Liu; Mike Wendland; Daniel Golovko; Tibor Schuster; Barbara Sennino; Donald M McDonald; Heike E Daldrup-Link
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

8.  Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells.

Authors:  Ali S Arbab; Gene T Yocum; Ali M Rad; Aarif Y Khakoo; Vicki Fellowes; Elizabeth J Read; Joseph A Frank
Journal:  NMR Biomed       Date:  2005-12       Impact factor: 4.044

9.  Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling.

Authors:  Michal Babic; Daniel Horák; Miroslava Trchová; Pavla Jendelová; Katerina Glogarová; Petr Lesný; Vít Herynek; Milan Hájek; Eva Syková
Journal:  Bioconjug Chem       Date:  2008-02-21       Impact factor: 4.774

Review 10.  In vivo MRI cell tracking: clinical studies.

Authors:  Jeff W M Bulte
Journal:  AJR Am J Roentgenol       Date:  2009-08       Impact factor: 3.959

View more
  42 in total

1.  Characterization of Magneto-Endosymbionts as MRI Cell Labeling and Tracking Agents.

Authors:  Kimberly D Brewer; Ryan Spitler; Kayla R Lee; Andrea C Chan; Joyce C Barrozo; Abdul Wakeel; Chandler S Foote; Steven Machtaler; James Rioux; Juergen K Willmann; Papia Chakraborty; Bradley W Rice; Christopher H Contag; Caleb B Bell; Brian K Rutt
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

2.  Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.

Authors:  He Wei; Oliver T Bruns; Michael G Kaul; Eric C Hansen; Mariya Barch; Agata Wiśniowska; Ou Chen; Yue Chen; Nan Li; Satoshi Okada; Jose M Cordero; Markus Heine; Christian T Farrar; Daniel M Montana; Gerhard Adam; Harald Ittrich; Alan Jasanoff; Peter Nielsen; Moungi G Bawendi
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

3.  Fluorine-19 Labeling of Stromal Vascular Fraction Cells for Clinical Imaging Applications.

Authors:  Laura C Rose; Deepak K Kadayakkara; Guan Wang; Amnon Bar-Shir; Brooke M Helfer; Charles F O'Hanlon; Dara L Kraitchman; Ricardo L Rodriguez; Jeff W M Bulte
Journal:  Stem Cells Transl Med       Date:  2015-10-28       Impact factor: 6.940

4.  Ferumoxytol Can Be Used for Quantitative Magnetic Particle Imaging of Transplanted Stem Cells.

Authors:  Hossein Nejadnik; Prachi Pandit; Olga Lenkov; Arian Pourmehdi Lahiji; Ketan Yerneni; Heike E Daldrup-Link
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

Review 5.  Basic science research in pediatric radiology - how to empower the leading edge of our field.

Authors:  Heike E Daldrup-Link
Journal:  Pediatr Radiol       Date:  2014-07-25

6.  Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.

Authors:  Florian Siedek; Anne M Muehe; Ashok J Theruvath; Raffi Avedian; Allison Pribnow; Sheri L Spunt; Tie Liang; Crystal Farrell; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2019-12-16       Impact factor: 5.315

Review 7.  The biological basis for concentrated iliac crest aspirate to enhance core decompression in the treatment of osteonecrosis.

Authors:  Stuart B Goodman
Journal:  Int Orthop       Date:  2018-02-12       Impact factor: 3.075

8.  The Protein Corona around Nanoparticles Facilitates Stem Cell Labeling for Clinical MR Imaging.

Authors:  Hossein Nejadnik; Seyed-Meghdad Taghavi-Garmestani; Steven J Madsen; Kai Li; Saeid Zanganeh; Phillip Yang; Morteza Mahmoudi; Heike E Daldrup-Link
Journal:  Radiology       Date:  2017-11-01       Impact factor: 11.105

9.  Iron administration before stem cell harvest enables MR imaging tracking after transplantation.

Authors:  Aman Khurana; Fanny Chapelin; Graham Beck; Olga D Lenkov; Jessica Donig; Hossein Nejadnik; Solomon Messing; Nikita Derugin; Ray Chun-Fai Chan; Amitabh Gaur; Barbara Sennino; Donald M McDonald; Paul J Kempen; Grigory A Tikhomirov; Jianghong Rao; Heike E Daldrup-Link
Journal:  Radiology       Date:  2013-07-12       Impact factor: 11.105

10.  Physicochemical characterization of ferumoxytol, heparin and protamine nanocomplexes for improved magnetic labeling of stem cells.

Authors:  L Henry Bryant; Saejeong J Kim; Matthew Hobson; Blerta Milo; Zsofia I Kovacs; Neekita Jikaria; Bobbi K Lewis; Maria A Aronova; Alioscka A Sousa; Guofeng Zhang; Richard D Leapman; Joseph A Frank
Journal:  Nanomedicine       Date:  2016-08-09       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.